SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): January 7, 2013
HASCO MEDICAL, INC.
(Exact name of registrant as specified in its charter)
(State or other jurisdiction
15928 Midway Rd., Addison, TX 75001
(Address of principal executive offices) (Zip Code)
Registrant’s telephone number, including area code: (214) 302-0930
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On January 7, 2013 the Board of Directors appointed Mr. Timothy Spence, age 55, to fill the vacant position of Chief Financial Officer.
Mr. Spence holds a BS in Accounting from the University of Southern California and a Juris Doctorate from Pepperdine University School of Law. He became a Certified Public Accountant in the State of California in 1982 and passed the California State Bar in 1998.
Mr. Spence is a financial management executive with experience in both start-ups and turnarounds. In addition to his financial management expertise, Mr. Spence will provide in-house legal management.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
HASCO MEDICAL, INC.
Date: January 7, 2013
/s/ Hal Compton, Jr.
Hal Compton, Jr.
Chief Executive Officer and President